軽度認知障害（MCI）は、認知機能（思考、知識、記憶など）の問題を伴う状態です。 MCIは、通常の老化の予想される認知機能低下と認知症のより深刻な低下の間の中間段階です。症状には、うつ病、過敏性と攻撃性、不安と無関心が含まれます。 危険因子には、糖尿病、高血圧、うつ病、喫煙、コレステロール値の上昇などがあります。
目次
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Mild Cognitive Impairment - Overview
Mild Cognitive Impairment - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Mild Cognitive Impairment - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Mild Cognitive Impairment - Companies Involved in Therapeutics Development
Mild Cognitive Impairment - Drug Profiles
Mild Cognitive Impairment - Dormant Projects
Mild Cognitive Impairment - Discontinued Products
Mild Cognitive Impairment - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Mild Cognitive Impairment, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Target, 2022 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Mechanism of Action, 2022 (Contd..1)
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Mild Cognitive Impairment - Dormant Projects, 2022
Mild Cognitive Impairment - Dormant Projects, 2022 (Contd..1)
Mild Cognitive Impairment - Dormant Projects, 2022 (Contd..2)
Mild Cognitive Impairment - Discontinued Products, 2022
List of Figures
Number of Products under Development for Mild Cognitive Impairment, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022
